Skip to content
TrialScanner

NCT05136898

Feasibility of Home Instillation of UGN-102 for Treatment of Low-Grade (LG) Non-Muscle Invasive Bladder Cancer (NMIBC)

Phase 3CompletedURGNLead

Registry record

Lead sponsor
UroGen Pharma Ltd.
Conditions
Bladder Cancer; Urothelial Carcinoma; Urothelial Carcinoma Bladder
Primary completion
Feb 2, 2023Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT05136898 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT05136898: Feasibility of Home Instillat... | TrialScanner